Alcon AG | ALC - Sales Revenues


Alcon AG reported $2.78B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
AstraZeneca USD 15.38B 90M Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
Essilor EUR 14.82B 351M Jun/2026
Fresenius EUR 5.95B 210M Jun/2026
Fresenius Medical Care EUR 4.86B 250M Jun/2026
GlaxoSmithKline GBP 8.41B 781M Jun/2026
GRIFOLS EUR 1.87B 170M Jun/2026
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.43B 300M Jun/2026
Novartis USD 14.41B 1.3B Jun/2026
Philips EUR 4.36B 450M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 11.95B 710M Jun/2026
Smith & Nephew USD 1.6B 1.58B Jun/2026
Sonova Holding CHF 1.82B 216.8M Dec/2025
UCB EUR 4.25B 764M Dec/2025